CD4 and diabetes mellitus: Studies of Unanue and colleagues (14) demonstrated that the delivery of a neutralizing antibody against the CSF1 receptor at 3 weeks of age in NOD mice results in the depletion of islet-resident macrophages and is accompanied by a reduction in CD4 T cells and DCs in the insulitic milieu and protects against diabetes.